Related Experiment Videos
Arylsulfatases in bilharziasis.
Summary
Urinary arylsulfatase A and B levels are elevated in bilharziasis patients, increasing with disease severity. This suggests a role for liver dysfunction in bilharzial bladder cancer development.
Area of Science:
- Biochemistry
- Parasitology
- Urology
Background:
- Bilharziasis (schistosomiasis) is a parasitic disease with significant health implications.
- Elevated urinary enzyme activity may indicate disease progression or complications.
Purpose of the Study:
- To quantify urinary arylsulfatase A and B levels in bilharziasis patients.
- To correlate enzyme activity with disease type and severity.
- To explore the link between liver dysfunction and bilharzial bladder cancer.
Main Methods:
- Urine samples analyzed from 18 healthy individuals and 50 bilharziasis patients.
- Patients categorized by infection type (haematobian, mansoni) and disease stage.
- Arylsulfatase A and B activity measured in all samples.
Main Results:
- Significantly elevated urinary arylsulfatase A and B activity observed in all patient groups.
- Enzyme activity showed a progressive increase with disease severity in both bilharziasis types.
- Liver dysfunction associated with bilharziasis may contribute to bladder cancer induction.
Conclusions:
- Urinary arylsulfatase A and B are potential biomarkers for bilharziasis activity and progression.
- The findings support a role for liver dysfunction in the pathogenesis of bilharzial bladder cancer.